Citi analyst Joanne Wuensch has given GE Healthcare Technologies Inc (GEHC) a Buy rating with a price target of $82.00. This comes as positive news for the company, as its shares closed at $66.28 yesterday.
Wuensch is a highly regarded analyst in the industry with a 5-star rating and an average return of 7.6%. She focuses on stocks in the healthcare sector, including Boston Scientific, Insulet, and Johnson & Johnson.
The analyst consensus on GE Healthcare Technologies Inc is currently a Moderate Buy, with an average price target of $87.89. This indicates that other analysts also have positive expectations for the company’s performance.
It is worth noting that GE Healthcare Technologies Inc has had a one-year high of $87.76 and a one-year low of $52.96. Currently, the average volume for the company’s shares is 3.02 million.
However, recent corporate insider activity has shown a negative sentiment towards the stock. There has been an increase in insiders selling their shares of GEHC over the past quarter compared to earlier in the year. CEO PDx O’Neill Kevin Michael, for example, sold 15,609.00 shares last month for a total of $1,206,949.20.
GE Healthcare Technologies Inc is a globally recognized company involved in medical technology, pharmaceutical diagnostics, and digital solutions innovation.
Source: Citi Analyst Joanne Wuensch, TipRanks, GEHC
